Image default
News

Japanese health ministry panel recommends approval of Alzheimer’s treatment Leqembi


A Japanese health ministry panel on Monday recommended approval of the Alzheimer’s disease treatment Leqembi, following standard approval for the drug granted by U.S. regulators last month.

REVANCE’S BOTOX RIVAL GETS FDA APPROVAL FOR PAINFUL NECK MUSCLE CONDITION

The expert panel’s decision sets the stage for official approval of the drug, co-developed by Japan’s Eisai and U.S.-based Biogen.

Alzheimer’s disease

Dr. Seth Gale points out evidence of Alzheimer’s disease on PET scans at the Center for Alzheimer Research and Treatment (CART) at Brigham and Women’s Hospital in Boston, Massachusetts, on March 30, 2023. (REUTERS/Brian Snyder/File Photo)

An Eisai executive said this month the company expects to begin marketing Leqembi in Japan within about 60 days of receiving insurance reimbursement approval from the country’s national health system.

CLICK HERE TO GET THE FOX NEWS APP



Source link

Вижте също..

Upcoming Marvel star rejected ‘huge’ Hollywood franchises to spend time with kids: ‘Feeds my soul’

admin

Lions waive injured Denzel Mims a month after trade with Jets, ending hopes of NFL career revitalization

admin

‘Read the room:’ Biden jokes about the ‘hot ground’ while observing Maui fire damage

admin

Utah children’s author dodges death row after DA’s ‘careful consideration’ with victim’s family

admin

Ted Carter, U of Nebraska head and Top Gun grad, tapped to serve as Ohio State’s next president

admin

Коментирай

Новини за турски сериали
Новини за турски сериали

Този уебсайт използва бисквитки , за да предостави на посетителите по добро качество. Добре Повече информация

Privacy & Cookies Policy